摘要
有研究证明电离辐射激活转录因子,从而引起治疗癌细胞的抵抗。这与激活促生存前信号通路和导致癌症发生发展有关。在不刺激的情况下,转录因子NF-κB是被隔离在细胞质中的,但是当细胞被电离辐射后,蛋白酶体通过IKK中IκB流动磷酸化蛋白酶降解,异常地导致NF-κB激活和核转位。因此,IκB降解、蛋白酶体作用、IKK磷酸蛋白酶和NF-κB核转位的干扰为抑制电离辐射诱导的NF-κB的副作用提供了坚定的策略。尽管NF-κB分子机制没有得到完整的解析,为了抑制由电离辐射引起的NF-κB,不同NF-κB抑制剂已经被使用。本文旨在强调电离辐射介导的NF-κB,如MG132、硼替佐米、姜黄色素、DHMEQ、橙皮苷、索拉菲尼以及银胶菊内酯在抑制电离辐射诱导的NF-κB副作用中的作用。此外也讨论了它们的化学结构特征和分子机制。
关键词: 转录因子;肿瘤;辐射增敏;辐射保护;辐射;NF-κB抑制剂
Current Medicinal Chemistry
Title:The Role of NF-κB Inhibitors in Cell Response to Radiation
Volume: 23 Issue: 34
Author(s): Sajjad Molavi Pordanjani, Seyed Jalal Hosseinimehr
Affiliation:
关键词: 转录因子;肿瘤;辐射增敏;辐射保护;辐射;NF-κB抑制剂
摘要: It is well documented that ionizing radiation (IR) activates the transcription factor (NF-κB) which is a trigger for resistance cancer cells to treatment. It is involved in activation of pro-survival signaling pathways and resulting in cancer development and progression. In unstimulated condition, NF-κB is sequestered in cytoplasm but after the cell exposure to IR, proteasomal degradation of IκB flowing phosphorylation via IKK, leads to aberrantly NF-κB activation and nuclear translocation. Therefore, interruption in IκB degradation, proteasome action, IKK phosphorylation and NF-κB nuclear translocation provide robust strategies for inhibiting adverse effect of IR induced NF-κB. In spite of uncompleted elucidation of NF-κB molecular mechanisms, different NF-κB inhibitors have been used in order to inhibiting the IR induced NF-κB. The aim of this review is to highlight the role of IR induced-NF-κB inhibitors such as MG132, bortezomib, curcumin, DHMEQ, naringin, sorafenib, genistein and parthenolide in suppression of IR induced NF-κB adverse effects. Moreover, their chemical, structural characteristics and molecular mechanisms will be discussed.
Export Options
About this article
Cite this article as:
Sajjad Molavi Pordanjani, Seyed Jalal Hosseinimehr , The Role of NF-κB Inhibitors in Cell Response to Radiation, Current Medicinal Chemistry 2016; 23 (34) . https://dx.doi.org/10.2174/0929867323666160824162718
DOI https://dx.doi.org/10.2174/0929867323666160824162718 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
MICA Gene and Relevance to Immune Responses in Organ Transplants and Inflammatory, Tumoral and Autoimmune Diseases
Current Immunology Reviews (Discontinued) Conventional Anticancer Therapeutics and Telomere Maintenance Mechanisms
Current Pharmaceutical Design Remodelling of the Ca2+ Toolkit in Tumor Endothelium as a Crucial Responsible for the Resistance to Anticancer Therapies
Current Signal Transduction Therapy Baicalin-induced Cytotoxicity and Apoptosis in Multidrug-resistant MC3/5FU Mucoepidermoid Carcinoma Cell Line
Letters in Drug Design & Discovery Synthesis and Evaluation of 99mTc Chelate-conjugated Bevacizumab
Current Radiopharmaceuticals Viral Disorder or Disordered Viruses: Do Viral Proteins Possess Unique Features?
Protein & Peptide Letters A Comprehensive Review on Ethnomedicinal, Pharmacological and Phytochemical Basis of Anticancer Medicinal Plants of Pakistan
Current Cancer Drug Targets The PAX8 / PPARγ Fusion Oncogene as a Potential Therapeutic Target in Follicular Thyroid Carcinoma
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Vitamin D Receptor is a Novel Drug Target for Ovarian Cancer Treatment
Current Cancer Drug Targets MicroRNA-203: Tumor Suppression and Beyond
MicroRNA Phytocompounds from the Medicinal and Dietary Plants: Multi-target Agents for Cervical Cancer Prevention and Therapy
Current Medicinal Chemistry Ultrasound Assisted-synthesis and Biological Evaluation of Piperazinylprop- 1-en-2-yloxy-2H-chromen-2-ones as Cytotoxic Agents
Letters in Drug Design & Discovery Cyclooxygenase-2: Potential Role in Regulation of Drug Efflux and Multidrug Resistance Phenotype
Current Pharmaceutical Design Nuclear Magnetic Resonance Spectroscopy of Lipids in Cancer
Current Organic Chemistry Prospects for Clinical Introduction of Nitroimidazole Antibiotics for the Treatment of Tuberculosis
Current Pharmaceutical Design Anticancer Drug Discovery Targeting DNA Hypermethylation
Current Medicinal Chemistry Potential of Alphavirus Vectors in the Treatment of Advanced Solid Tumors
Recent Patents on Anti-Cancer Drug Discovery Methods of Screening-Purification and Antimicrobial Potentialities of Bacteriocin in Health Care
Current Drug Metabolism Bioadhesive Films as Drug Delivery Systems
Drug Delivery Letters Automated PET Radiotracer Manufacture on the BG75 System and Imaging Validation Studies of [18F]fluoromisonidazole ([18F]FMISO)
Current Radiopharmaceuticals